Form 4: Korro Bio Director Lucchino Acquires Stock Options
SEC Form 4 Filing
Director David L. Lucchino acquired stock options in Korro Bio, Inc. on June 11, 2024.
Summary
- On June 11, 2024, David L. Lucchino, a director of Korro Bio, Inc., acquired stock options to purchase 5,190 shares of common stock at an exercise price of $42.19 per share.
- The options vest fully on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, contingent upon continued service as a non-employee director.
- Following the transaction, Lucchino directly owns 5,190 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a stock option grant to a director. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation.
Stakeholder Impact
- The acquisition of stock options by a director can align their interests with those of shareholders, potentially incentivizing them to work towards increasing the company's value.
Key Dates
| Date | Description |
|---|---|
| 06/11/2024 | Date of stock option transaction |
| 06/10/2034 | Expiration date of the stock options |
| 06/12/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.